XBIO
Xenetic Biosciences Inc
Halal Rating :
Last Price
$4.30
Last updated:
Market Cap
-
7D Change
5.39%
1 Year Change
24.64%
Company Overview
Industries
Exchange
Next Earnings Date
Xenetic Biosciences Inc is a biopharmaceutical company focused on developing innovative drug delivery platforms and therapeutic vaccines. The company leverages its proprietary drug delivery platform technologies, including PolyXen and DNase, to develop next-generation biologic drugs with improved therapeutic profiles for rare and orphan diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $614243.0 | $1.05m | - | $-61298.0 | 0.00% | 5.82% |
| June 30, 2024 | $726404.0 | $2.0m | - | $-63447.0 | 0.00% | 3.17% |
| March 31, 2024 | $510817.0 | $1.71m | - | $-73249.0 | 0.00% | 4.29% |
Company Impact
Help us evaluate Xenetic Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.